Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SACK: Apixaban for Stroke Prevention in CKD Stage 5 with AF
NCT05679024Phase 3Recruiting
- Sponsor
- Region Stockholm
- Start
- Feb 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by Region Stockholm. Started Feb 2023; status: recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05679024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05679024.